# Final Report: Speech-Based Early Detection of Alzheimer's Disease Using Machine Learning

## Executive Summary

This project implements a comprehensive end-to-end system for analyzing speech patterns to identify potential indicators of Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI). The system combines acoustic feature extraction, linguistic analysis, and machine learning models with strict subject-level data separation to prevent data leakage.

## Project Architecture

### System Components

1. **Data Preprocessing**
   - Audio preprocessing (resampling, silence trimming, normalization)
   - Text preprocessing (cleaning, tokenization, lemmatization)
   - Subject-level train/validation/test splitting

2. **Feature Extraction**
   - Acoustic features: MFCCs, spectrogram, pitch, pause patterns, jitter/shimmer
   - Linguistic features: TTR, MTLD, syntactic complexity, repetitions
   - Pretrained embeddings: wav2vec 2.0, HuBERT, BERT, Sentence Transformers

3. **Machine Learning Models**
   - Baseline: Logistic Regression, Random Forest, SVM, XGBoost, MLP
   - Advanced: Multimodal fusion with attention mechanisms

4. **Evaluation & Explainability**
   - Comprehensive metrics (accuracy, precision, recall, F1, ROC-AUC, PR-AUC)
   - SHAP, LIME, permutation importance
   - Cross-validation and ablation studies

5. **Deployment**
   - Streamlit web interface
   - FastAPI REST API
   - Docker containerization

## Performance Targets vs. Reality

### Target Metrics
- Accuracy: >90%
- ROC-AUC: >0.95

### Important Considerations

**These targets are aspirational.** Actual performance depends on:

1. **Dataset Characteristics**: Size, quality, demographic representation
2. **Recording Conditions**: Audio quality, background noise
3. **Task Difficulty**: Distinguishing early MCI from normal aging is challenging
4. **Subject Independence**: Strict subject-level separation reduces optimistic bias

### Reporting Policy

This system follows rigorous evaluation standards:
- All results reported with complete subject separation
- No data leakage between train/validation/test sets
- Full transparency about limitations
- Performance metrics include confidence intervals where applicable

If targets cannot be achieved under rigorous evaluation, actual performance will be reported honestly with full explanation of limitations.

## Ethical Safeguards

### Privacy Protection
- Data anonymization before processing
- Secure storage requirements
- Compliance with HIPAA/GDPR where applicable

### Fairness Considerations
- Monitoring performance across demographic groups
- Class weighting for imbalanced datasets
- Regular bias audits recommended

### Informed Consent
- Required for any clinical application
- Clear communication about research nature
- Right to withdraw at any time

### Disclaimer

⚠️ **CRITICAL**: This system is a **RESEARCH SCREENING TOOL** only.

- NOT FDA approved
- NOT intended for standalone diagnosis
- Results must be interpreted by qualified healthcare professionals
- Requires integration with comprehensive clinical assessment

## Technical Implementation

### Key Design Decisions

1. **Subject-Level Splitting**: Prevents data leakage by ensuring all samples from the same individual are in a single split

2. **Multi-Modal Approach**: Combines acoustic and linguistic features for comprehensive analysis

3. **Explainability First**: Built-in SHAP, LIME, and feature importance for transparent predictions

4. **Reproducibility**: Fixed random seeds, version control, detailed logging

### Limitations

1. **Language Dependency**: Primarily trained on English speech
2. **Demographic Bias**: Performance may vary across underrepresented groups
3. **Comorbidity Confusion**: May not distinguish AD from other cognitive disorders
4. **Early Stage Detection**: Very early MCI detection remains challenging
5. **Recording Quality**: Performance degrades with poor audio quality

## Future Directions

1. **Multilingual Support**: Extend to non-English languages
2. **Longitudinal Analysis**: Track changes over time
3. **Integration**: Combine with other biomarkers (imaging, genetics)
4. **Clinical Validation**: Rigorous prospective clinical trials
5. **Regulatory Pathway**: Pursue FDA/CE approval for clinical use

## Usage Instructions

### Quick Start

```bash
# Install dependencies
pip install -r requirements.txt

# Prepare data
python src/preprocessing/data_preparation.py

# Extract features
python src/features/extract_features.py

# Train models
python src/models/train.py

# Evaluate
python src/evaluation/evaluate.py

# Launch web interface
streamlit run src/api/app.py
```

### API Usage

```python
from src.preprocessing.audio_preprocessing import AudioPreprocessor
from src.features.acoustic_features import AcousticFeatureExtractor
from src.models.train import BaselineModels

# Preprocess
preprocessor = AudioPreprocessor()
audio, _ = preprocessor.preprocess("sample.wav")

# Extract features
extractor = AcousticFeatureExtractor()
features = extractor.extract_feature_vector(audio, 16000)

# Predict
models = BaselineModels()
# ... load trained model and predict
```

## Conclusion

This project provides a robust framework for speech-based Alzheimer's detection research. While the target metrics of >90% accuracy and >0.95 AUC represent meaningful goals, actual performance must be evaluated honestly under rigorous conditions. The system prioritizes transparency, explainability, and ethical considerations over optimistic performance claims.

The true value of this system lies not in achieving arbitrary metrics but in providing researchers and clinicians with a reliable, interpretable tool that can contribute to early detection efforts when used appropriately within a comprehensive clinical assessment framework.

---

**Version**: 1.0.0  
**Date**: 2024  
**Status**: Research Use Only
